Navigation Links
Pharmasset Accesses up to $30 Million of Working Capital
Date:10/4/2007

>

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: (609) 613-4125

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation the risk that Pharmasset does not receive all or any portion of the funds from the working capital loan agreement with Horizon, the risk that we will default on any of the loans causing all of the loans to be immediately due and payable and allowing Horizon to terminate the loan agreement, the risk that adverse events could cause the cessation of the Phase 3 studies and/or our development of clevudine, the risk that the registration clinical trials of clevudine will not be successful or will not provide meaningful data, the risk that the on- going or anticipated clinical trials for any one or more of our product candidates will not be successfully developed or will not provide clinically meaningful data and the risk that any one or more of our product candidates will not be commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Venture Investors early-stage fund grows to $115 million
2. Two convicted of selling $6 million in counterfeit Rockwell software on eBay
3. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
4. TomoTherapy raises $223 million in IPO
5. Fiserv reports $113.5 million in Q1 profit
6. Investors raise $25 million for biodiesel plant
7. Grow Milwaukee includes millions for tech funding
8. Mirus Bio, Pfizer enter multimillion-dollar research agreement
9. ConjuGon raises $3.3 million to fund clinical trials
10. TrafficCast secures $1 million line of credit
11. Make Mine a $Million shoots for May program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...Taxpayer Bill of Rights proposal are aiming direct...venue limits on state, county, and municipal gover...ss climate. , ,TABOR, they say, places economic de... in jeopardy. , ,Based in part on Colorado,s TABOR...ent would be handcuffed should the measure be enac...
...ay be a flat state, but at BIO 2006 in Chicago it,... hope will draw people from across the exhibition ...wer with lighted displays, which Forward Wisconsi... in Madison before the April 9-12 event. , ,Jan Al...sconsin, is coordinating company involvement in th...
...n as an emerging biotechnology hot spot will be fu...epresented at one of the world,s premier biotechno...e hope. , ,Wisconsin attendees will make up 1.5 pe...ogy Industry Organization,s International Conventi...ormick Place Convention Center. That,s more than m...
... a day when the fledgling Biomedical Technology Al...lity, receiving $500,000 from the Wisconsin Dept. ...s, it was an anecdote from a chemistry professor t...r collaboration between academic researchers. , ,I...stitutional partnerships that are expected to resu...
Other Biology Technology:Critics say tax limits could handcuff tech investment 2Critics say tax limits could handcuff tech investment 3Critics say tax limits could handcuff tech investment 4Critics say tax limits could handcuff tech investment 5State pavilion goes for height, style at BIO expo 2Wisconsin to show up at BIO in numbers 2Wisconsin to show up at BIO in numbers 3Alliance looks to create the right chemistry in SE Wisconsin 2Alliance looks to create the right chemistry in SE Wisconsin 3
(Date:10/3/2008)...he appointment of Esin Gulari, dean of the College... to serve on the National Science Board (NSB). Pre...t along with six other distinguished scientists. ,...st and an engineer," said Gulari. "On the NSB, I w...on a national level. I hope that my participation ...
(Date:10/3/2008)...idies of cellulosic ethanol production and use hav...o an international group of scientists which inclu...d Oklahoma State University. , The 23-member gr...ce-based policy to address this global issue for t...ce, OU botany professor, and Michael Palmer, OSU b...
(Date:10/3/2008)...conspicuous traits produced by melanin pigments (f... some birds and fishes). These traits are used as ...ibute to increase the mating opportunities. Howeve...ds on the fact that they transmit honest informati...only assured by the fact that producing or maintai...
(Date:10/3/2008)...posture and exercise power is due to humans, evolu...iversity of New South Wales (UNSW). , Prehistori...what is perceived as their "turf" and ostracising ...onplace in everyday work situations than many of u...was carried out in hospitals. , "This tribal cul...
Breaking Biology News(10 mins):US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board 2Oklahoma researchers support biodiversity in biofuels production 2Traits produced by melanin may signal the bearer's capacity to combat free radicals 2Why your boss is white, middle-class and a show-off 2Symposium on energy research highlights future challenges opportunities 2819 1Symposium on energy research highlights future challenges opportunities 2819 2Manufactured Buckyballs dont harm microbes that clean the environment 2817 1Manufactured Buckyballs dont harm microbes that clean the environment 2817 2Manufactured Buckyballs dont harm microbes that clean the environment 2817 3Manufactured Buckyballs dont harm microbes that clean the environment 2817 4Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 1Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 2Northwest Hospital 26 Medical Center Earns Distinguished Hospital Award for Patient Safety 16276 3Lupus Webchat April 9 Features Ask the Doctor Open Forum 16274 1Lupus Webchat April 9 Features Ask the Doctor Open Forum 16274 2
...d smoking have a high rate of co-occurrence in the...e co-morbidity of alcoholism and smoking among Ame... Clinical & Experimental Research , researcher...g Plains American Indians, as well as the influenc...ional polymorphism called Val158Met may have on th...
...h self-assembly technique for growing replacement ...ntire articular surface of knees damaged by arthri... Musculoskeletal Bioengineering Laboratory, is des... Engineering. , "This has significant ramification...rst time, about the potential treatment of entire ...
... microbiology textbook aimed at undergraduate stud... Written by eminent scientists with practical te...Microbe, will engage students in the learning proc...ique perspective of the field. , "Our working plan...gh facts have a tendency to creep in," says Moseli...
...s have just learned another lesson from nature. Af...eate self-medications, such as anti-fungal agents,...entists already knew that a particular enzyme was ...oncoctions to generate a large family of medically...ducts. The question was, how do they do it? , Che...
Other Biology News:Alcoholism, smoking and genetics among Plains American Indians 2Alcoholism, smoking and genetics among Plains American Indians 3Rice bioengineers pioneer techniques for knee repair 2Microbiology text tells stories, offers online resources 2MIT chemist discovers secret behind nature's medicines 2